Parkinson Disease Treatment in Hospitals and Nursing Facilities: Avoiding Pitfalls

被引：19

作者：

Ahlskog, J. Eric ^{[1
]}

机构：

[1] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA

来源：

MAYO CLINIC PROCEEDINGS | 2014年 / 89卷 / 07期

关键词：

PAIN THRESHOLD; LEVODOPA; ROPINIROLE; INHIBITORS;

D O I：

10.1016/j.mayocp.2014.02.018

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The unique needs of patients with Parkinson disease challenge staff when such patients are admitted to hospitals or nursing facilities. Prolongation of the hospital stay, falls with injuries, fainting, or declining motor function may result from therapeutic misadventures or failure to anticipate common problems. Staff familiarity with Parkinson disease, and especially carbidopa-levodopa dosing and dynamics, may prevent such problems and streamline hospital and nursing home care. (C) 2014 Mayo Foundation for Medical Education and Research

引用

收藏

页码：997 / 1003

页数：7

相关论文

共 14 条

[1] Rasagiline, Parkinson neuroprotection, and delayed-start trials Still no satisfaction? [J].

Ahlskog, J. Eric ;

Uitti, Ryan J. .

NEUROLOGY, 2010, 74 (14) :1143-1148

[2] CONTROLLED-RELEASE SINEMET (CR-4) - A DOUBLE-BLIND CROSSOVER STUDY IN PATIENTS WITH FLUCTUATING PARKINSONS-DISEASE [J].

AHLSKOG, JE ;

MUENTER, MD ;

MCMANIS, PG ;

BELL, GN ;

BAILEY, PA .

MAYO CLINIC PROCEEDINGS, 1988, 63 (09) :876-886

[3]

Ahlskog JE, 2005, PARKINSONS DIS TREAT, P532

[4]

Ahlskog JE, 2009, PARKINSONS DIS TREAT, P382

[5]

Ahlskog JE, 2013, DEMENTIA LEWY BODIES, P244

[6] New, selective catechol-O-methyltransferase inhibitors as therapeutic agents in Parkinson's disease [J].

Bonifati, V ;

Meco, G .

PHARMACOLOGY & THERAPEUTICS, 1999, 81 (01) :1-36

[7] Effect of levodopa on pain threshold in Parkinson's disease: A clinical and positron emission tomography study [J].

Brefel-Courbon, C ;

Payoux, P ;

Thalamas, C ;

Ory, F ;

Quelven, I ;

Chollet, F ;

Montastruc, JL ;

Rascol, O .

MOVEMENT DISORDERS, 2005, 20 (12) :1557-1563

[8] SLOW RECOVERY OF HUMAN BRAIN MAO-B AFTER L-DEPRENYL (SELEGELINE) WITHDRAWAL [J].

FOWLER, JS ;

VOLKOW, ND ;

LOGAN, J ;

WANG, GJ ;

MACGREGOR, RR ;

SCHLYER, D ;

WOLF, AP ;

PAPPAS, N ;

ALEXOFF, D ;

SHEA, C ;

DORFLINGER, E ;

KRUCHOWY, L ;

YOO, K ;

FAZZINI, E ;

PATLAK, C .

SYNAPSE, 1994, 18 (02) :86-93

[9] Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study [J].

Gerdelat-Mas, A. ;

Simonetta-Moreau, M. ;

Thalamas, C. ;

Ory-Magne, F. ;

Slaoui, T. ;

Rascol, O. ;

Brefel-Courbon, C. .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (10) :1140-1142

[10] Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum [J].

Gerlach, M ;

Double, K ;

Arzberger, T ;

Leblhuber, F ;

Tatschner, T ;

Riederer, P .

JOURNAL OF NEURAL TRANSMISSION, 2003, 110 (10) :1119-1127